<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html><!-- InstanceBegin template="/Templates/submenus.dwt" codeOutsideHTMLIsLocked="false" -->
<head>
<!-- InstanceBeginEditable name="doctitle" -->
<TITLE>PNI.org | Pacific Neuropsychiatric Institute</TITLE>
<!-- InstanceEndEditable --> 
<META NAME="description" CONTENT="The Pacific Neuropsychiatric Institute
(PNI) is involved with comprehensive evaluation and management in
Neuropsychiatry and Psychopharmacology at the clinical, research,
forensic, education and phenomenologic levels.">
<META NAME="keywords" CONTENT="Vernon Neppe, medicine, psychopharmacology,
neuropsychiatry, forensic psychiatry, neuropsychiatric, institute,
education, lectures, brain, forensics, journal, internet journal, Neppe,
neurotransmitters, medical ethics, questionnaire, research instruments,
caffeine, philosophy, vortex pluralism, epileptology, anomalous, informed
consent, pharmacology, neuropsychology, clinical medicine, mental health,
brain injury, epilepsy, seizure, head injury, deja vu, anomalistic
experience, parapsychology, phenomenology, psychiatric, medical, drug,
BROCAS SCAN, STRAW, INSET, NMBPRS, PBRS, mental status, MMPI, SCL-90,
MMSE, Electroencephalogram, Electroencephalography, EEG, Ambulatory
monitoring, Ambulatory EEG, ventricular dilatation, MRI head, CT head,
SPECT head, PET head, competency, statistics, litigation, competence,
deposition, evidence, ethics, pharmacokinetics, pharmacodynamics, P450,
side-effects, tachyphylaxis, FDA, in vitro, in vivo, receptorology, civil
litigation, DSM, internet journal of Neuropsychiatry and
Psychopharmacology, JINEPP, INEPP, medical books, innovative
psychopharmacotherapy, partial agonist, agonist, antagonist, receptor,
synapse, autoreceptor, post-synaptic, pre-synaptic, down regulation, up
regulation, supersensitivity, subsensitivity, GABA, NMDA, receptor
subtypes, serotonin, norepinephrine, acetylcholine, benzodiazepine,
dopamine, opiates, chloride ionophore, pituitary, hypothalamus, temporal
lobe, frontal lobe, parietal lobe, occipital lobe, cerebral cortex,
kindling, chindling, bathtub, pushbuttons, motivation, MSE, mental status
examination, cognition, affect, volition, lesion localization,
psychomotor, dangerousness, environmental interaction, memory,
concentration, normality, organic brain syndrome, behavioral neurologist,
sleep, obesity, bariatric medicine, EMG, Electromyography, Nerve
conduction, antidepressant, anxiolytic, anxioselectivity, psychostimulant,
beta blocker, beta blockade, anticonvulsant, adjunctive therapy, appetite
suppressants, computer therapy, computerized diagnosis, memory retraining,
speech retraining, neuropharmacology, neuropharmacologist,
psychopharmacology, psychopharmacologist, anxiety, depression, OCD, ADD,
ADHD, attention deficit hyperactivity disorder, aggression, irritability,
tardive dyskinesia, movement disorder, neurology, Parkinson's, headache,
pain, sexual dysfunction, fibromyalgia, obsessive compulsive, Alzheimer's,
seizure, epilepsy, epileptic, TLE, CPS, closed head injury, CHIT, CHIP,
MTBI, PTSD, traumatic brain injury, methylphenidate, Ritalin, zolpidem,
Ambien, nadolol, Corgard, pemoline, Cylert, selegeline, nitrous oxide,
azapirones, phenytoin, Dilantin, topiramate, Topamax, tiagabine, Gabitril,
valproate, Depakote, felbamate, Felbatol, gabapentin, Neurontin,
carbamazepine, Tegretol, lamotrigine, Lamictal, neuroleptics, sumatriptan,
Imitrex, Sinemet, carbidopa, SSRI, sertraline, paroxetine, fluvoxamine,
fluoxetine, Zoloft, Paxil, Prozac, Luvox, bupropion, Wellbutrin, tricyclic
antidepressant, amitriptyline, imipramine, bromocriptine, Eldepryl,
Aricept, donepezil, pergolide, Cognex, tacrine, Parlodel, cyclobenzaprine,
Flexeril, phentermine, Buspar, buspirone, nefazodone, Serzone,
venlafaxine, Effexor, clozapine, Clozaril, perphenazine, Trilafon,
mirtazapine, Remeron, recreational drugs, firearms, cigarette, marijuana,
cannabinol, herbal remedies, St John's Wort, anti-oxidant,
proanthocyanadin, vitamin, mineral, melatonin, herbal, cannabis, tea,
coffee, cola drinks, pyridoxine, vitamin, mineral, ascorbic acid,
ascorbate, B6, anxiety, neurosis, depression, post-traumatic stress
disorder, Alzheimer's, dementia, cognitive deterioration, premenstrual
syndrome, PMS, panic, eating disorders, migraine, schizophrenia, bipolar
illness, manic, depression, mania, temporal lobe dysfunction, phobia,
pervasive developmental disorder, PDD, autism, obsessive compulsive
disordor, psychosis, refractory conditions, narcolepsy, drug abuse,
alcoholism, extrasensory perception, ESP, delta, psi, afferent, efferent,
subjective, vortex, paranormal, psychic, psychokinesis, PK, out of body
experience, OOBE, OBE, near death experience, NDE, survival, veridical,
dream, telepathy, clairvoyance, precognition, retrocognition, mediumship,
ectoplasm, aura, psychometry, remote viewing, Ganzfeld, deja entendu,
geomagnetic, deja pense, deja senti, deja pressenti, anomalous,
spontaneous, reincarnation, forced choice, Zener cards, experient,
non-experient, altered state, consciousness, phenomenologic">

<LINK REL="stylesheet" TYPE="text/css" HREF="../../styles.css">

<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">

<script language="JavaScript" type="text/JavaScript">
<!--
function MM_displayStatusMsg(msgStr) { //v1.0
  status=msgStr;
  document.MM_returnValue = true;
}
//-->
</script>
<!-- InstanceBeginEditable name="head" --><!-- InstanceEndEditable -->
</head>

<body text="#000000" link="#990000" vlink="#990000" alink="#990000" onLoad="MM_displayStatusMsg('PNI.org | Pacific Neuropsychiatric Institute');return document.MM_returnValue">
<a name="top"></a> 
<table width="700" border="1" align="center" cellpadding="0" cellspacing="0" bordercolor="#000000">
  <tr> 
    <td><table width="100%" border="0" cellpadding="0" cellspacing="0" bgcolor="C4D2FF">
        <tr> 
          <td><a href="/"><img src="../../header.jpg" width="700" height="127" border="0"></a></td>
        </tr>
        <tr>
          <td>
		  <div align="right">
				<a href="http://brainvoyage.com/" target="new_window">www.brainvoyage.com</a>
				 | <a href="http://vernonneppe.org/" target="new_window">www.vernonneppe.org</a>
				 | <a href="http://vernonneppe.com/" target="new_window">www.vernonneppe.com</a>
				 | <a href="http://ecao.us/" target="new_window">www.ecao.us</a>
				 | <a href="http://healthyharmony.com/" target="new_window">www.healthyharmony.com</a>&nbsp;
			</div>
			<div align="left" >
				<script>
				  (function() {
					var cx = '009175660163571863627:du9tocqgd6q';
					var gcse = document.createElement('script');
					gcse.type = 'text/javascript';
					gcse.async = true;
					gcse.src = 'https://cse.google.com/cse.js?cx=' + cx;
					var s = document.getElementsByTagName('script')[0];
					
					s.parentNode.insertBefore(gcse, s);
				  })();
				</script>
				<gcse:search></gcse:search>
			</div>
			<table width="100%" border="0" cellspacing="0" cellpadding="15">
              <tr>
                <td width="100%"><p><font size="3" face="Arial, Helvetica, sans-serif"><strong>
                    <a href="http://pni.org/neuropsychiatry/">NEUROPSYCHIATRY and BEHAVIORAL NEUROLOGY</a>
                     | 
                    <a href="http://pni.org/psychopharmacology/">PSYCHOPHARMACOLOGY</a><br><a href="http://pni.org/forensics/">FORENSICS</a> | <a href="/research/">RESEARCH</a>
					 | 
                    <a href="http://pni.org/consciousness/">CONSCIOUSNESS</a>
					 | 
                    <a href="http://pni.org/philosophy/">PHILOSOPHY</a> | <a href="http://www.brainvoyage.com/ctbm/">BOOKS</a> | <a href="/books/">LITERATURE</a><br>
                    <a href="http://pni.org/perspective.html">PERSPECTIVES</a>
                    | <a href="http://pni.org/clinical/">CLINICAL</a> | <a href="http://pni.org/research/anomalous/deja/">D&Eacute;J&Agrave; VU</a> | 
                    <a href="http://pni.org/interesting/">INTERESTING AREAS</a> | <a href="http://pni.org/philosophy/ethics/">ETHICS</a>
                    | <a href="http://pni.org/about_pni.html">CONTACT</a></strong></font></p>
                <p>
					<strong>
						KEY ARTICLES (MEDICAL):
						<a href="http://pni.org/neuropsychiatry/chit/">HEAD INJURY</a> | 
						<a href="http://pni.org/neuropsychiatry/narcolepsy/">NARCOLEPSY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/paroxysmal/">PAROXYSMAL DISORDERS</a> | 
						<a href="http://pni.org/psychopharmacology/principles/">PRESCRIPTION PRINCIPLES</a> | 
						<a href="http://www.pni.org/psychopharmacology/generics">GENERIC SUBSTITUTION</a> | 
						<a href="http://www.pni.org/neuropsychiatry/tardive_dyskinesia/">TARDIVE DYSKINESIA</a> |
						<a href="http://pni.org/key-articles/double-blind.html">DOUBLE BLIND</a>
						</strong>
						<p>
					<strong>
						ENDURING INTEREST:
						<a href="http://www.pni.org/groundbreaking/">GROUNDBREAKING PARADIGM SHIFTS</a> | 
						<a href="http://www.pni.org/philosophy/">PHILOSOPHY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/moral_philosophy/">MORAL PHILOSOPHY</a> | 
						<a href="http://www.pni.org/neuropsychiatry/consciousness/">CONSCIOUSNESS</a> | 
						<a href="http://pni.org/key-articles/deja-vu.html">DEJA VU</a> | 
						
						<a href="http://www.pni.org/intelligence/">GENIUS</a> | 
						
						<a href="http://www.pni.org/ethics/security/">ZMAIL</a>					
					 </strong>
				</td>
              </tr>
            </table>
            <table width="100%" border="0" cellspacing="0" cellpadding="0">
              <tr> 
                <td class="bodyText" valign="top"><!-- InstanceBeginEditable name="content" -->
                  <p> </p>
                  <p align="center"></p>
                  <table width="650" border="0" align="center" cellpadding="5" cellspacing="0">
                    <tr> 
                      <td width="74%" valign="top"><div align="center"> 
                          <H1>Possible Temporal Lobe Symptoms</H1>
                          <P>VERNON M NEPPE MD, PhD(Med)</P>
                          <P align="left"> Seizure disorders with behavioral disturbance, 
                            may initially be interpreted as psychiatric in origin. 
                            Many such problems relate to the temporal lobe of 
                            the brain. The features of temporal lobe epilepsy 
                            and non-epileptic dysfunction of the temporal lobe 
                            are so varied and so protean that it is necessary 
                            to classify them. I have suggested the term <B>"Possible 
                            temporal lobe symptoms"</B> (PTLSs) relate to features 
                            which can be induced by stimulating areas of the temporal 
                            lobe during neurosurgery. These symptoms only become 
                            specific symptoms of temporal lobe dysfunction if 
                            their occurrence is validated empirically during a 
                            seizure - either through observation or by the electroencephalogram 
                            (hence the word "possible" in possible temporal lobe 
                            seizures). Great care must be taken in interpretation 
                            of such features : For example, using a phenomenological 
                            analysis, I demonstrated that the symptom of deja 
                            vu commonly regarded as symptomatic of temporal lobe 
                            epilepsy indeed had a very special phenomenologic 
                            quality in patients <I>with temporal lobe epilepsy</I>. 
                            Like many other such focal symptoms, this involves 
                            its association with <I>post-ictal features</I> such 
                            as sleepiness, headache and clouded consciousness 
                            and its link in time with these features. This association 
                            provides an excellent clue to the existence of temporal 
                            lobe epilepsy. However, deja vu is a normal phenomenon 
                            occurring in 70 percent of the population and unless 
                            such phenomenological detail is obtained, patients' 
                            symptomatology may be misinterpreted. I similarly 
                            studied olfactory hallucinations but a specific type 
                            of temporal lobe epilepsy olfactory hallucination 
                            could not be demonstrated although there were suggestive 
                            features. A <I>major message, therefore, may be the 
                            relevance of adequately assessing the symptomatology 
                            of patients presenting with epilepsy. It may be that 
                            this is a direction as relevant as electroencephalographic 
                            monitoring</I>. Most of all it reminds us how slender 
                            our interpretations of other related but different 
                            symptoms such as "he experiences strange smells" might 
                            be and the fact that it is critical to elicit whether 
                            these are episodic in quality and linked with other 
                            symptomatology particularly epileptic or temporal 
                            lobe. A written test instrument designed to screen 
                            for such symptoms which I use in clinical practice 
                            is the <A HREF="../instruments/inset/">INSET</A> - 
                            The <I>INVENTORY OF NEPPE OF SYMPTOMS OF EPILEPSY 
                            AND THE TEMPORAL LOBE</I> (INSET). The INSET involves 
                            screening for possible temporal lobe, epileptic and 
                            organic symptoms and spells. Thereafter the symptoms 
                            are categorized into several headers namely nonspecific 
                            symptoms, possible and controversial temporal lobe 
                            symptoms, seizure related and other focal features. 
                            The test is based on the subject and / or his family 
                            responding to questions which are thereafter elaborated 
                            in greater clinical detail. Responses are at two time 
                            levels: current as well as the most common frequency 
                            in the remote past and require the patient to rank 
                            frequency from never through less than yearly to more 
                            than daily (i.e. 0-6). Questions in the INSET have 
                            been based on the earlier Neppe Temporal Lobe Questionnaire 
                            which itself derived from an intensive literature 
                            review on the topic. The INSET plus medical history 
                            is a major determining factor for whether to order 
                            follow-up specialized electroencephalograms such as 
                            <A HREF="eeg.html">ambulatory EEG</A>. </P>
                          <H2 align="left">TABLE: POSSIBLE TEMPORAL LOBE SYMPTOMS 
                            (PTLSs)</H2>
                          <P align="left"><I>Controversial PTLSs (CPTLSs)</I></P>
                          <div align="left">
                            <OL>
                              <LI>severe hypergraphia 
                              <LI>severe hyperreligiosity 
                              <LI>polymodal hallucinatory experience Paroxysmal 
                                (Recurrent) Episodes of: 
                              <LI>profound mood changes within hours 
                              <LI>frequent subjective paranormal experiences e.g. 
                                telepathy, mediumistic trance, writing automatisms, 
                                visualization of presences or of lights/colors 
                                round people, dream ESP, out-of body experiences, 
                                alleged healing abilities 
                              <LI>intense libidinal change 
                              <LI>Uncontrolled, lowly precipitated, directed, 
                                non-amnesic aggressive episodes; 
                              <LI>recurrent nightmares of stereotyped kind 
                              <LI>episodes of blurred vision or diplopia 
                            </OL>
                          </div>
                          <P align="left"><I>Not Necessarily Disintegrative PTLSs 
                            (NPTLSs)</I></P>
                          <P align="left">Symptoms Not Necessarily Requiring Treatment 
                            Paroxysmal (Recurrent) Episodes of:</P>
                          <div align="left">
                            <OL>
                              <LI>Complex visual hallucinations linked to other 
                                qualities of perception such as voices, emotions, 
                                or time </LI>
                            </OL>
                          </div>
                          <OL>
                            <P align="left">Any form of:</P>
                            <LI>
                              <div align="left">Auditory perceptual abnormality; 
                              </div>
                            <LI>
                              <div align="left">Olfactory hallucinations; </div>
                            <LI>
                              <div align="left">Gustatory hallucinations; </div>
                            <LI>
                              <div align="left">Rotation or disequilibrium feelings 
                                linked to other perceptual qualities; </div>
                            <LI>
                              <div align="left">Unexplained "sinking," "rising," 
                                or "gripping" epigastric sensations; </div>
                            <LI>
                              <div align="left">Flashbacks; </div>
                            <LI>
                              <div align="left">Illusions of distance, size (micropsia, 
                                macroscopy), (micropsia), loudness, tempo, strangeness, 
                                unreality, fear, sorrow; </div>
                            <LI>
                              <div align="left">Hallucinations of indescribable 
                                modality. </div>
                            <LI>
                              <div align="left">Temporal lobe epileptic deja vu 
                                (has associated ictal or postictal features {headache, 
                                sleepiness ,confusion} linked to the experience 
                                in clear or altered consciousness ) </div>
                            <LI>
                              <div align="left">Any CPTLSs which appear to improve 
                                after administration of an anticonvulsant agent 
                                such as carbamazepine. </div>
                          </OL>
                          <P align="left"><I>Disintegrative PTLSs (DPTLSs)</I></P>
                          <P align="left">Symptoms Requiring Treatment: Paroxysmal 
                            (Recurrent) Episodes of:</P>
                          <div align="left">
                            <OL>
                              <LI>Epileptic amnesia; 
                              <LI>Lapses in consciousness; 
                              <LI>Conscious "confusion" ("clear" consciousness 
                                but abnormal orientation, attention and behavior); 
                              <LI>Epileptic automatisms; 
                              <LI>Masticatory-salivatory episodes; 
                              <LI>Speech automatisms; 
                              <LI>"Fear which comes of itself" linked to other 
                                disorders (hallucinatory or unusual autonomic) 
                                ; 
                              <LI>Uncontrolled, unprecipitated, undirected, amnesic 
                                aggressive episodes; 
                              <LI>Superior quadrantic homonymous hemianopia; 
                              <LI>Receptive (Wernicke's) aphasia. 
                              <LI>Any CPTLSs or NPTLSs with ictal EEG correlates. 
                            </OL>
                          </div>
                          <P align="left"><I>Seizure related features ( SZs )</I></P>
                          <P align="left"> Any typical absence, tonic or clonic 
                            or tonic-clonic or bilateral myoclonic seizures in 
                            the absence of metabolic, intoxication or withdrawal 
                            related phenomena. </P>
                          <P align="left"> Clearly there is a greater need to 
                            pay attention to unusual episodic symptoms. This will 
                            ultimately lead to a workable classification and the 
                            recognition that certain seizure like features need 
                            be treated by psychiatrists. </P>

</div>
                        <div align="left">
                          <MULTICOL COLS=2>
                          </MULTICOL>
                        </div>
                        <P align="right"><font face="Arial, Helvetica, sans-serif"><a href="#top"><img src="../../top.gif" width="48" height="19" border="0"></a></font></P></td>
                    </tr>
                  </table>
                  <p>&nbsp;</p>
                  <!-- InstanceEndEditable --> 
                  <p>&nbsp;</p>
				  </td>
              </tr>
            </table>
            
          </td>
        </tr>
        <tr>
          <td height="29"><img src="../../bottom.jpg" width="700" height="29" border="0" usemap="#Map3"></td>
        </tr>
      </table></td>
  </tr>
</table>
<p align="center"><br>
  <font size="2" face="Arial, Helvetica, sans-serif">Copyright &copy;1997-2018 
  Pacific Neuropsychiatric Institute</font><br>
</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<map name="Map3">
  <area shape="rect" coords="237,3,385,23" href="http://pni.org/about_pni.html">
  <area shape="rect" coords="410,5,566,25" href="http://www.pni.org/disclaimer.html">
  <area shape="rect" coords="582,3,682,26" href="http://www.pni.org/credits.html">
</map>
</body>
<!-- InstanceEnd --></html>
